BAT investment leaves Reinet gasping
British American Tobacco has come under increased regulatory scrutiny for its products, including e-cigarettes
Reinet suffered collateral damage as the share price of British American (BAT), which makes up the biggest share of its net asset value, dropped. BAT and other global tobacco companies have come under increased regulatory scrutiny for their tobacco products, including e-cigarettes. Reinet’s net asset value dropped to €4.8bn in the six months to end-September, from €5.4bn a year ago, as the share of BAT slipped to £35.845, from £46.72 a year before. The value of Reinet’s investment in BAT shrunk to €2.738bn, from €3.606bn a year ago. Reinet said in a statement that the US Food and Drug Administration’s continued regulation weighed on the tobacco industry. The investment vehicle controlled by billionaire Johann Rupert holds 68.1-million shares in BAT, representing about 2.97% of BAT’s issued share capital. Earlier in the week, BAT plummeted 11% after Wall Street Journal reported that the US government is considering banning menthol cigarettes. But the value of Reinet’s investment in U...
Would you like to comment on this article?
Sign up (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Subscribe now to unlock this article.
Support BusinessLIVE’s award-winning journalism for R129 per month (digital access only).
There’s never been a more important time to support independent journalism in SA. Our subscription packages now offer an ad-free experience for readers.
Cancel anytime.
Questions? Email helpdesk@businesslive.co.za or call 0860 52 52 00. Got a subscription voucher? Redeem it now.